These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

776 related articles for article (PubMed ID: 27045424)

  • 1. Gastro-intestinal tract: The leading role of mucosal immunity.
    Steinert A; Radulovic K; Niess J
    Swiss Med Wkly; 2016; 146():w14293. PubMed ID: 27045424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut microbiota-derived metabolites as key actors in inflammatory bowel disease.
    Lavelle A; Sokol H
    Nat Rev Gastroenterol Hepatol; 2020 Apr; 17(4):223-237. PubMed ID: 32076145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The gut microbiota and inflammatory bowel disease.
    Goto Y; Kurashima Y; Kiyono H
    Curr Opin Rheumatol; 2015 Jul; 27(4):388-96. PubMed ID: 26002031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of Gastrointestinal Immunity by Metabolites.
    Gu BH; Kim M; Yun CH
    Nutrients; 2021 Jan; 13(1):. PubMed ID: 33430497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The involvement of gut microbiota in inflammatory bowel disease pathogenesis: potential for therapy.
    Cammarota G; Ianiro G; Cianci R; Bibbò S; Gasbarrini A; Currò D
    Pharmacol Ther; 2015 May; 149():191-212. PubMed ID: 25561343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bridging intestinal immunity and gut microbiota by metabolites.
    Wang G; Huang S; Wang Y; Cai S; Yu H; Liu H; Zeng X; Zhang G; Qiao S
    Cell Mol Life Sci; 2019 Oct; 76(20):3917-3937. PubMed ID: 31250035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of gut microbiota fecal metabolites by chromatographic targeted approaches.
    Fiori J; Turroni S; Candela M; Gotti R
    J Pharm Biomed Anal; 2020 Jan; 177():112867. PubMed ID: 31614303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Bacterial Metabolites on Gut Barrier Function and Host Immunity: A Focus on Bacterial Metabolism and Its Relevance for Intestinal Inflammation.
    Gasaly N; de Vos P; Hermoso MA
    Front Immunol; 2021; 12():658354. PubMed ID: 34122415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Manipulating resident microbiota to enhance regulatory immune function to treat inflammatory bowel diseases.
    Mishima Y; Sartor RB
    J Gastroenterol; 2020 Jan; 55(1):4-14. PubMed ID: 31482438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fecal Microbiota Transplantation in Inflammatory Bowel Disease: A Primer for Internists.
    Syal G; Kashani A; Shih DQ
    Am J Med; 2018 Sep; 131(9):1017-1024. PubMed ID: 29605414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Microbiota and inflammatory bowel disease: an update.].
    De Sire R; Talocco C; Petito V; Lopetuso LR; Graziani C; Gasbarrini A; Scaldaferri F
    Recenti Prog Med; 2018 Dec; 109(12):570-573. PubMed ID: 30667386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microbial Metabolites Determine Host Health and the Status of Some Diseases.
    Sittipo P; Shim JW; Lee YK
    Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31653062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Cross-Talk Between Microbiota-Derived Short-Chain Fatty Acids and the Host Mucosal Immune System Regulates Intestinal Homeostasis and Inflammatory Bowel Disease.
    Gonçalves P; Araújo JR; Di Santo JP
    Inflamm Bowel Dis; 2018 Feb; 24(3):558-572. PubMed ID: 29462379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physiological Role of Gut Microbiota for Maintaining Human Health.
    Andoh A
    Digestion; 2016; 93(3):176-81. PubMed ID: 26859303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How to Manipulate the Microbiota: Fecal Microbiota Transplantation.
    Fuentes S; de Vos WM
    Adv Exp Med Biol; 2016; 902():143-53. PubMed ID: 27161356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Microbiome in Crohn's Disease: Role in Pathogenesis and Role of Microbiome Replacement Therapies.
    Khanna S; Raffals LE
    Gastroenterol Clin North Am; 2017 Sep; 46(3):481-492. PubMed ID: 28838410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Manipulation of epithelial integrity and mucosal immunity by host and microbiota-derived metabolites.
    Kayama H; Takeda K
    Eur J Immunol; 2020 Jul; 50(7):921-931. PubMed ID: 32511746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The therapeutic potential of manipulating gut microbiota in obesity and type 2 diabetes mellitus.
    Kootte RS; Vrieze A; Holleman F; Dallinga-Thie GM; Zoetendal EG; de Vos WM; Groen AK; Hoekstra JB; Stroes ES; Nieuwdorp M
    Diabetes Obes Metab; 2012 Feb; 14(2):112-20. PubMed ID: 21812894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Xenobiotic and endobiotic handling by the mucosal immune system.
    Chen ML; Sundrud MS
    Curr Opin Gastroenterol; 2018 Nov; 34(6):404-412. PubMed ID: 30299289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Intestinal immune response is regulated by gut microbe].
    Tanemoto S; Sujino T; Kanai T
    Nihon Rinsho Meneki Gakkai Kaishi; 2017; 40(6):408-415. PubMed ID: 29367525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.